READ: The Supreme Court rules against big pharma

The court is allowing the Federal Trade Commission to keep pursuing pharmaceutical companies for "pay to delay" arrangements, wherein the companies pay generic manufacturers to keep cheap versions of drugs off the market. The case is FTC v. Actavis.

Stephen Breyer wrote the opinion, joined by Anthony Kennedy, Sonia Sotomayor, Ruth Bader Ginsburg, and Elena Kagan. John Roberts dissented, joined by Clarence Thomas and Antonin Scalia. Samuel Alito recused himself.

http://www.washingtonpost.com/blogs/wonkblog/files/2013/06/ftc_actavis.pdf

business

wonkblog

Success! Check your inbox for details. You might also like:

Please enter a valid email address

See all newsletters

Comments
Show Comments
Most Read Business

business

wonkblog

Success! Check your inbox for details.

See all newsletters

Next Story
Dylan Matthews · June 17, 2013